本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

IO Biotech, Inc.

1.39
-0.1100-7.33%
成交量:28.39萬
成交額:38.77萬
市值:9,157.45萬
市盈率:-0.93
高:1.50
開:1.50
低:1.20
收:1.50
資料載入中...
2022/04/14

重要事件披露

8-K - Current report
2022/03/31

重要事件披露

8-K - Current report
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/17

重要事件披露

8-K - Current report
2021/12/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/12/06

重要事件披露

8-K - Current report
2021/11/19

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/05

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933